A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy

BACKGROUND: It remains unclear how information about aromatase inhibitors (AI) impacts women’s decision-making about persistence with endocrine therapy. PURPOSE: To describe and compare how women treated for primary early stage breast cancer either persisting or not persisting with an AI received, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieters, Huibrie C., Green, Emily, Khakshooy, Sally, Sleven, Miriam, Stanton, Annette L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354984/
https://www.ncbi.nlm.nih.gov/pubmed/30703119
http://dx.doi.org/10.1371/journal.pone.0210972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354984/
https://www.ncbi.nlm.nih.gov/pubmed/30703119
http://dx.doi.org/10.1371/journal.pone.0210972

Ejemplares similares